Brief: Gensight Biologics: Preliminary Assay Indicating Successful Manufacture Of Second LUMEVOQ GMP Batch

Gensight Biologics SA

13/11/2023 06:43

Nov 13 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS ANNOUNCES PRELIMINARY ASSAY INDICATING
SUCCESSFUL MANUFACTURE OF SECOND LUMEVOQ® GMP BATCH
    * VG TITER RESULTS TO BE CONFIRMED BY AN INDEPENDENT
LABORATORY IN
NEXT FEW DAYS
    * LATEST BATCH IS SECOND ONE TO CONFIRM SUCCESSFUL
IMPLEMENTATION
OF CORRECTIONS IDENTIFIED IN REMEDIATION PLAN
    * PREPARATIONS UNDERWAY FOR MANUFACTURE OF THIRD PLANNED GMP
BATCH
    * BATCH MAY PROVIDE PRODUCT SUPPLY IN BEGINNING OF Q2 2024
FOR
POTENTIAL RESUMPTION OF EARLY ACCESS PROGRAM AND INITIATION OF
NEW RECOVER CLINICAL TRIAL, AS WELL AS ADDITIONAL DATA FOR
PLANNED REGULATORY SUBMISSION

Source text for Eikon:  ID:nBw8QDScya 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))